FREDUN

FREDUN PHARMACEUTICALS

Small Cap BSE: 539730 NSE: FREDUN
₹969.00
72.55 (8.09%)
As on 20 August, 2022 | 10:28

Fredun Pharmaceuticals Share Price

Fredun Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Fredun Pharmaceuticals Share Returns

  • Over 1 Month 15.38%
  • Over 3 Month -1.1%
  • Over 6 Month 7.35%
  • Over 1 Year 145.04%

Fredun Pharmaceuticals Key Statistics

Fredun Pharmaceuticals Investment Rating

  • Master Rating:
  • Fredun Pharmaceuticals has an operating revenue of Rs. 225.04 Cr. on a trailing 12-month basis. An annual revenue growth of 67% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 62%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 11% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Fredun Pharmaceuticals Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 48
  • 69
  • 53
  • 54
  • 45
  • 41
  • Operating Expenses Qtr Cr
  • 45
  • 66
  • 50
  • 51
  • 44
  • 40
  • Operating Profit Qtr Cr
  • 4
  • 3
  • 3
  • 4
  • 1
  • 2
  • Depreciation Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • Interest Qtr Cr
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • Tax Qtr Cr
  • 0
  • 1
  • 1
  • 1
  • 0
  • 0
  • Net Profit Qtr Cr
  • 1
  • 2
  • 2
  • 2
  • 0
  • 1

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
961.15
64.7 (7.22%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 930.29
  • 50 Day
  • 914.8
  • 100 Day
  • 898.74
  • 200 Day
  • 857.59
  • 20 Day
  • 960.92
  • 50 Day
  • 883.72
  • 100 Day
  • 932.56
  • 200 Day
  • 859

Fredun Pharmaceuticals Resistance and Support

PIVOT
₹904.02
Resistance
  • First Resistance
  • 915.84
  • Second Resistance
  • 935.22
  • Third Resistance
  • 947.04
Support
  • First Resistance
  • 884.64
  • Second Resistance
  • 872.82
  • Third Resistance
  • 853.44
  • RSI
  • 55.56
  • MFI
  • 39.89
  • MACD Single Line
  • 14.46
  • MACD
  • 7.66

Fredun Pharmaceuticals Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 6,156
  • 480,476
  • 78.05
  • Week
  • 5,050
  • 410,070
  • 81.21
  • 1 Month
  • 3,002
  • 235,207
  • 78.35
  • 6 Month
  • 2,362
  • 190,017
  • 80.46

Fredun Pharmaceuticals Result Highlights

Fredun Pharmaceuticals Synopsis

BSE-Medical-Diversified

Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 133.89 Cr. and Equity Capital is Rs. 3.99 Cr. for the Year ended 31/03/2021. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.
  • Market Cap
  • 430
  • Sales
  • 225
  • Shares in Float
  • 0.22
  • No of funds
  • 1
  • Yield
  • 0.07
  • Book Value
  • 6.26
  • U/D Vol ratio
  • 1.1
  • LTDebt / Equity
  • 62
  • Alpha
  • 0.41
  • Beta
  • 0.95

Fredun Pharmaceuticals

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Nov-21
  • Promoters
  • 51.04%
  • 51.27%
  • 51.27%
  • Financial Institutions/ Banks
  • 1.68%
  • 1.69%
  • 1.69%
  • Individual Investors
  • 42.02%
  • 41.8%
  • 41.91%
  • Others
  • 5.26%
  • 5.24%
  • 5.13%

Fredun Pharmaceuticals Management

  • Name
  • Designation
  • Dr.(Mrs.) Daulat N Medhora
  • Chairman & Jt. M. D
  • Mr. Fredun N Medhora
  • Managing Director & CFO
  • Mr. Nariman B Medhora
  • Whole Time Director
  • Dr. Chandrakant K Shah
  • Ind. Non-Executive Director
  • Dr. Rohinton Kanga
  • Ind. Non-Executive Director
  • Dr. Aspi N Raimalwala
  • Ind. Non-Executive Director

Fredun Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Fredun Pharmaceuticals Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-12
  • Quarterly Results
  • 2022-05-16
  • Audited Results & Final Dividend
  • 2022-01-28
  • Quarterly Results
  • 2021-11-06
  • Quarterly Results
  • 2021-08-10
  • Quarterly Results

Fredun Pharmaceuticals FAQs

What is Share Price of Fredun Pharmaceuticals ?

Fredun Pharmaceuticals share price is ₹969 As on 20 August, 2022 | 10:14

What is the Market Cap of Fredun Pharmaceuticals ?

The Market Cap of Fredun Pharmaceuticals is ₹433.4 Cr As on 20 August, 2022 | 10:14

What is the P/E ratio of Fredun Pharmaceuticals ?

The P/E ratio of Fredun Pharmaceuticals is 62.1 As on 20 August, 2022 | 10:14

What is the PB ratio of Fredun Pharmaceuticals ?

The PB ratio of Fredun Pharmaceuticals is 6.3 As on 20 August, 2022 | 10:14

Q1FY23